Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbora Malecova

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Nature Communications|September 12, 2018
Dynamics of cellular states of fibro-adipogenic progenitors during myogenesis and muscular dystrophyBarbora Malecova, Sole Gatto, Usue Etxaniz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 13, 2026
Delpacibart Etedesiran Improves the Molecular Pathology of Myotonic Dystrophy Type 1 in the Phase 1/2 MARINA® StudyTanya T Kwan, Qingying Meng, Nathaniel Delos Santos, et al.
The EMBO Journal|November 10, 2011
Signal-dependent incorporation of MyoD-BAF60c into Brg1-based SWI/SNF chromatin-remodelling complexSonia V Forcales, Sonia Albini, Lorenzo Giordani, et al.
Nucleic Acids Research|April 17, 2026
Development of a DUX4-targeting antibody oligonucleotide conjugate as a therapy for FSHDBarbora Malecova, David Sala, Garineh M Melikian, et al.
Nucleic Acids Research|May 24, 2023
Targeted tissue delivery of RNA therapeutics using antibody-oligonucleotide conjugates (AOCs)Barbora Malecova, Rob S Burke, Michael Cochran, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nature Communications|September 12, 2018
Dynamics of cellular states of fibro-adipogenic progenitors during myogenesis and muscular dystrophyBarbora Malecova, Sole Gatto, Usue Etxaniz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 13, 2026
Delpacibart Etedesiran Improves the Molecular Pathology of Myotonic Dystrophy Type 1 in the Phase 1/2 MARINA® StudyTanya T Kwan, Qingying Meng, Nathaniel Delos Santos, et al.
The EMBO Journal|November 10, 2011
Signal-dependent incorporation of MyoD-BAF60c into Brg1-based SWI/SNF chromatin-remodelling complexSonia V Forcales, Sonia Albini, Lorenzo Giordani, et al.
Nucleic Acids Research|April 17, 2026
Development of a DUX4-targeting antibody oligonucleotide conjugate as a therapy for FSHDBarbora Malecova, David Sala, Garineh M Melikian, et al.
Nucleic Acids Research|May 24, 2023
Targeted tissue delivery of RNA therapeutics using antibody-oligonucleotide conjugates (AOCs)Barbora Malecova, Rob S Burke, Michael Cochran, et al.
Pageof 2